tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACIU Stock Latest News

AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
Company AnnouncementsAC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
13d ago
6K
ACIU
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
PremiumThe Fly
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
13d ago
ACIU
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027
PremiumCompany Announcements
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027
20d ago
6K
ACIU
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
PremiumRatings
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
3M ago
ACIU
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
PremiumThe Fly
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
3M ago
ACIU
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
PremiumCompany AnnouncementsAC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
3M ago
6K
ACIU
Promising Potential of AC Immune SA’s Vaccine Platform in Parkinson’s Disease: A Buy Rating by Andrew Fein
Premium
Ratings
Promising Potential of AC Immune SA’s Vaccine Platform in Parkinson’s Disease: A Buy Rating by Andrew Fein
4M ago
ACIU
AC Immune SA Reports Decline in Q3 2025 Financial Results
Premium
Company Announcements
AC Immune SA Reports Decline in Q3 2025 Financial Results
4M ago
6K
ACIU
AC Immune reports Q3 EPS (CHF 0.16) vs. CHF 0.05 last year
PremiumThe Fly
AC Immune reports Q3 EPS (CHF 0.16) vs. CHF 0.05 last year
4M ago
ACIU
AC Immune sees cash runway to end of 3Q27
PremiumThe Fly
AC Immune sees cash runway to end of 3Q27
4M ago
ACIU
AC Immune reduced workforce by around 30% following strategic review
PremiumThe Fly
AC Immune reduced workforce by around 30% following strategic review
4M ago
ACIU
AC Immune appoints Mummery as Chair of Clinical Advisory Board
PremiumThe Fly
AC Immune appoints Mummery as Chair of Clinical Advisory Board
4M ago
ACIU
AC Immune’s ACI-24.060 Study: A Potential Game-Changer in Alzheimer’s Treatment
PremiumCompany AnnouncementsAC Immune’s ACI-24.060 Study: A Potential Game-Changer in Alzheimer’s Treatment
4M ago
ACIU
AC Immune’s Innovative PET Tracer Study: A Potential Game-Changer for Neurodegenerative Diagnostics
Premium
Company Announcements
AC Immune’s Innovative PET Tracer Study: A Potential Game-Changer for Neurodegenerative Diagnostics
4M ago
ACIU
AC Immune’s Innovative PET Radioligand Study: A Potential Game-Changer in Neurodegenerative Diagnostics
Premium
Company Announcements
AC Immune’s Innovative PET Radioligand Study: A Potential Game-Changer in Neurodegenerative Diagnostics
4M ago
ACIU
AC Immune SA: Pioneering Innovations in Neurodegenerative Disease Treatment and Diagnostics
PremiumRatings
AC Immune SA: Pioneering Innovations in Neurodegenerative Disease Treatment and Diagnostics
4M ago
ACIU
AC Immune announces publication of preclinical data on ACI-19626
PremiumThe Fly
AC Immune announces publication of preclinical data on ACI-19626
5M ago
ACIU
AC Immune announces publication of results on ACI-35.030 in eBioMedicine
PremiumThe Fly
AC Immune announces publication of results on ACI-35.030 in eBioMedicine
6M ago
JNJ
ACIU
AC Immune SA: Strategic Focus and Innovative Platforms Drive Buy Rating Amid Promising Immunotherapy Developments
PremiumRatings
AC Immune SA: Strategic Focus and Innovative Platforms Drive Buy Rating Amid Promising Immunotherapy Developments
6M ago
ACIU
AC Immune SA Announces Strategic Focus and Workforce Reduction
PremiumCompany AnnouncementsAC Immune SA Announces Strategic Focus and Workforce Reduction
6M ago
6K
ACIU
AC Immune Reports Q2 2025 Financial Progress
Premium
Company Announcements
AC Immune Reports Q2 2025 Financial Progress
7M ago
ACIU
AC Immune SA: Promising Pipeline and Strong Financial Position Justify Buy Rating
Premium
Ratings
AC Immune SA: Promising Pipeline and Strong Financial Position Justify Buy Rating
7M ago
ACIU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >